Nektar Therapeutics (NKTR) Insider Trading

Total insider buys:
  • $1,135,850.00
Total insider sells:
  • $232,543,735.70
Most recent insider trade:
  • Nov. 19, 2024
Most active insider trader:
  • Howard W Robin
Trader NameDateTitleAmountPriceTypeTotal Value
July 21, 2021Director3,524$16.81Sell$59,238.44
May 17, 2021SVP1,917$18.30Sell$35,081.10
May 17, 2021Insider31,111$18.30Sell$569,331.30
May 17, 2021CFO7,898$18.30Sell$144,533.40
May 17, 2021CAO13,391$18.30Sell$245,055.30
May 17, 2021CEO11,560$18.30Sell$211,548.00
May 12, 2021Director8,000$19.34Sell$154,720.00
April 14, 2021Director8,000$18.98Sell$151,840.00
Feb. 4, 2021CFO50,000$19.81Sell$990,500.00
Feb. 3, 2021SVP5,344$19.45Sell$103,940.80
Feb. 3, 2021CEO150,000$19.72Sell$2,958,000.00
Feb. 2, 2021CFO50,000$20.17Sell$1,008,500.00
Jan. 28, 2021CAO75,000$18.62Sell$1,396,500.00
Dec. 15, 2020Director1,560$17.82Sell$27,799.20
Nov. 23, 2020Insider16,380$16.40Sell$268,632.00
Sept. 28, 2020Director3,250$17.25Sell$56,062.50
Sept. 25, 2020Director5,500$17.75Sell$97,625.00
Sept. 21, 2020Director2,250$19.74Sell$44,415.00
Sept. 17, 2020CFO2,000$19.96Sell$39,920.00
Sept. 8, 2020Director8,000$18.53Sell$148,240.00
Aug. 17, 2020CAO1,367$19.67Sell$26,888.89
Aug. 17, 2020CEO11,885$19.67Sell$233,777.95
Aug. 17, 2020SVP1,529$19.67Sell$30,075.43
Aug. 17, 2020CFO6,245$19.67Sell$122,839.15
Aug. 17, 2020Insider26,200$19.67Sell$515,354.00
July 9, 2020Director15,009$25.00Sell$375,225.00
April 15, 2020Director8,000$18.38Sell$147,040.00
March 11, 2020Director8,000$16.79Sell$134,320.00
Feb. 18, 2020CEO8,448$22.35Sell$188,812.80
Feb. 18, 2020CFO5,938$22.35Sell$132,714.30
Feb. 18, 2020CAO1,394$22.35Sell$31,155.90
Feb. 18, 2020Insider4,774$22.35Sell$106,698.90
Feb. 12, 2020Director8,000$23.50Sell$188,000.00
Feb. 6, 2020CAO37,500$22.78Sell$854,250.00
Nov. 18, 2019CFO8,863$17.97Sell$159,268.11
Nov. 18, 2019Insider3,960$17.97Sell$71,161.20
Nov. 18, 2019CAO2,713$17.97Sell$48,752.61
Nov. 18, 2019CEO13,556$17.97Sell$243,601.32
Nov. 13, 2019CFO25,000$19.79Sell$494,750.00
Oct. 16, 2019CEO33,334$17.48Sell$582,678.32
Oct. 15, 2019CFO25,000$15.83Sell$395,750.00
Oct. 14, 2019Major Shareholder29,127$36.72Sell$1,069,543.44
Sept. 30, 2019Director2,375$18.06Sell$42,892.50
Sept. 27, 2019Director4,000$17.99Sell$71,960.00
Sept. 20, 2019Director2,250$20.24Sell$45,540.00
Sept. 16, 2019CFO25,000$20.52Sell$513,000.00
Sept. 5, 2019SVP15,000$17.28Buy$259,200.00
Aug. 16, 2019CEO12,551$18.15Sell$227,800.65
Aug. 16, 2019CFO5,063$18.15Sell$91,893.45
Aug. 16, 2019COO3,819$18.15Sell$69,314.85
  • Insiders are both buying and selling Nektar Therapeutics stock.

  • The insider traders at Nektar Therapeutics are: Howard W Robin, Gil M. Labrucherie, Jillian B. Thomsen, Robert Chess, Jonathan Zalevsky, John Nicholson, Gil M Labrucherie, Howard W. Robin, Stephen K Doberstein, Jillian B Thomsen, Lutz Lingnau, Mark Andrew Wilson, Ivan P Gergel, Maninder Hora, Jeffrey Robert Ajer, R Scott Greer, Dennis L Winger, Christopher A Kuebler, Myriam Curet, Susan Wang, Christopher A. Kuebler, Roy A Whitfield, Karin Eastham, Curet Myriam, Roy Whitfield, John Northcott, Deep Track Capital, Lp, Stephen K. Doberstein, and Katharina Otto-Bernstein

  • The most active insider trader at Nektar Therapeutics is Howard W Robin with 49 trades.

  • Howard W Robin has sold the most Nektar Therapeutics stock with a total value of $84,286,240.28.

  • Roy A Whitfield has bought the most Nektar Therapeutics stock with a total value of $1,256,500.00.

  • The most recent insider trade for Nektar Therapeutics was on Nov. 19, 2024.

  • The single biggest insider buy for Nektar Therapeutics was from Roy A Whitfield with a total value of $628,250.00 on Aug. 10, 2017.

  • The single biggest insider sell for Nektar Therapeutics was from John Nicholson with a total value of $21,853,694.88 on March 7, 2018.